ATE339496T1 - Modulation von gamma-secretase aktivität - Google Patents

Modulation von gamma-secretase aktivität

Info

Publication number: ATE339496T1
Authority: AT; Austria
Prior art keywords: app; gamma; secretase; assay; modulation
Prior art date: 2000-05-11

Application number

AT01935260T

Other languages

English (en)

Inventor

Barbara Cordell

Jeffrey N Higaki

Mitchell Mutz

Original Assignee

Scios Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-11

Filing date

2001-05-09

Publication date

2006-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22754280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE339496(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-09 Application filed by Scios Inc filed Critical Scios Inc

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE339496T1 publication Critical patent/ATE339496T1/de

Links

102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title abstract 5
108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title abstract 5
230000000694 effects Effects 0.000 title abstract 2
210000004027 cell Anatomy 0.000 abstract 3
238000003556 assay Methods 0.000 abstract 2
230000035772 mutation Effects 0.000 abstract 2
DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 abstract 1
210000000170 cell membrane Anatomy 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
230000002255 enzymatic effect Effects 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Neurosurgery (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Psychiatry (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Holo Graphy (AREA)
Investigating Or Analysing Biological Materials (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT01935260T 2000-05-11 2001-05-09 Modulation von gamma-secretase aktivität ATE339496T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US20350600P	2000-05-11	2000-05-11

Publications (1)

Publication Number	Publication Date
ATE339496T1 true ATE339496T1 (de)	2006-10-15

Family

ID=22754280

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01935260T ATE339496T1 (de)	2000-05-11	2001-05-09	Modulation von gamma-secretase aktivität

Country Status (8)

Country	Link
US (2)	US6579689B2 (de)
EP (1)	EP1305406B2 (de)
JP (1)	JP2003532413A (de)
AT (1)	ATE339496T1 (de)
AU (1)	AU2001261368A1 (de)
DE (1)	DE60123074T3 (de)
DK (1)	DK1305406T4 (de)
WO (1)	WO2001085924A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2405332A1 (en) *	2000-04-03	2001-10-11	Bristol-Myers Squibb Company	Fluorescence assay for gamma-secretase activity and inhibitors
US20030022251A1 (en) *	2001-07-04	2003-01-30	Boehringer Ingelheim Pharma Kg	Gamma-secretase in vitro screening assay
IL162838A0 (en)	2002-01-04	2005-11-20	Univ Rockefeller	Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
DE60329995D1 (de) *	2002-04-24	2009-12-24	Hiroshi Mori	Gamma-sekretase-inhibitoren
EP1858325A4 (de) *	2005-01-07	2010-06-30	Roskamp Res Llc	Verbindungen zur hemmung der beta-amyloidproduktion und verfahren zum identifizieren dieser verbindungen
JP6166534B2 (ja)	2009-08-05	2017-07-19	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	新規調節タンパク質および阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4372888A (en) †	1980-08-26	1983-02-08	The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services	Nondenaturing zwitterionic detergents
CA2191924A1 (en)	1995-12-05	1997-06-06	Kevin Felsenstein	5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production
GB9608657D0 (en)	1996-04-26	1996-07-03	Smithkline Beecham Plc	Novel treatment
WO1998015828A1 (en) *	1996-10-07	1998-04-16	Scios Inc.	Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
US6313268B1 (en) †	1998-10-16	2001-11-06	Vivian Y. H. Hook	Secretases related to Alzheimer's dementia
DE19941039A1 (de)	1999-08-28	2001-03-01	Boehringer Ingelheim Pharma	gamma-Sekretase in vitro Testsystem
DE10000161A1 (de)	2000-01-06	2001-07-19	Boehringer Ingelheim Pharma	Verfahren zur Identifikation eines Proteaseinhibitors
CA2405332A1 (en)	2000-04-03	2001-10-11	Bristol-Myers Squibb Company	Fluorescence assay for gamma-secretase activity and inhibitors

2001
- 2001-05-09 AT AT01935260T patent/ATE339496T1/de not_active IP Right Cessation
- 2001-05-09 EP EP01935260.8A patent/EP1305406B2/de not_active Expired - Lifetime
- 2001-05-09 DE DE60123074.4T patent/DE60123074T3/de not_active Expired - Lifetime
- 2001-05-09 AU AU2001261368A patent/AU2001261368A1/en not_active Abandoned
- 2001-05-09 WO PCT/US2001/015089 patent/WO2001085924A2/en not_active Ceased
- 2001-05-09 US US09/852,914 patent/US6579689B2/en not_active Expired - Lifetime
- 2001-05-09 DK DK01935260.8T patent/DK1305406T4/en active
- 2001-05-09 JP JP2001582513A patent/JP2003532413A/ja active Pending
2003
- 2003-06-17 US US10/464,036 patent/US20030211559A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20010055782A1 (en)	2001-12-27
EP1305406B1 (de)	2006-09-13
DK1305406T4 (en)	2015-02-02
WO2001085924A2 (en)	2001-11-15
DE60123074T3 (de)	2015-01-29
DE60123074T2 (de)	2007-03-01
AU2001261368A1 (en)	2001-11-20
DE60123074D1 (de)	2006-10-26
DK1305406T3 (da)	2007-01-08
WO2001085924A3 (en)	2003-02-27
JP2003532413A (ja)	2003-11-05
US6579689B2 (en)	2003-06-17
EP1305406B2 (de)	2014-11-12
US20030211559A1 (en)	2003-11-13
EP1305406A2 (de)	2003-05-02

Legal Events

Date	Code	Title	Description
2007-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE450635T1 (de)	2009-12-15	Elektrochemische herstellung von peroxo- dischwefelsäure unter einsatz von diamantbeschichteten elektroden
ATE342962T1 (de)	2006-11-15	Zusammensetzungen und verfahren für verbesserte zellkultur
DE69634640D1 (de)	2005-05-25	Mutierte alpha-amylase enzyme mit erhöhter stabilität
Fox et al.	1997	Identification of potential activators of proteinase‐activated receptor‐2 1
DE60144015D1 (de)	2011-03-24	Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
DE60232234D1 (de)	2009-06-18	Verfahren zur kultivierung von circovirus
IL150168A0 (en)	2002-12-01	Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
DE60141950D1 (de)	2010-06-10	Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
WO2003076932A3 (de)	2004-09-02	Detektion und analyse von protein-interaktionen in vivo
WO2001016285A3 (en)	2001-09-13	Novel proteases and variants thereof
ATE430589T1 (de)	2009-05-15	Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE59903410D1 (de)	2002-12-19	Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
AR018023A1 (es)	2001-10-31	Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
MXPA03005548A (es)	2004-04-20	Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
ATE474926T1 (de)	2010-08-15	Verwendung von clya hemolysin fur ausscheidung von fusionprotein
ATE339496T1 (de)	2006-10-15	Modulation von gamma-secretase aktivität
BR0313083A (pt)	2007-07-17	moléculas de adamts4 modificadas,polinucleotìdeo, vetor, processos para produção, composição farmacêutica, bem como uso das mesmas
AU7843101A (en)	2001-12-17	Furin polypeptides with improved characteristics
WO2003021265A8 (en)	2004-07-01	Genetic construct intracellular monitoring system
ATE415487T1 (de)	2008-12-15	Biologisches testverfahren für thyroid stimulierende antikörper
WO1999037758A3 (en)	1999-09-30	Expression of proteolytically-sensitive peptides
ATE334592T1 (de)	2006-08-15	Biologische bekämpfung von nematoden
WO2003059932A3 (en)	2004-01-29	Methods of inducing or enhancing connective tissue repair
DE69930819D1 (de)	2006-05-24	Nicht-enzymatische methoden zur erzeugung von chemilumineszenz bei acridan-alkenen
WO2003006947A3 (en)	2003-05-08	Cell-screening assay and composition